{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:44:46Z","timestamp":1791819886417,"version":"4.3.4"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020581","name":"AIRC Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["5 per Mille 2018 - ID. 21198"],"award-info":[{"award-number":["5 per Mille 2018 - ID. 21198"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.semcancer.2026.102615","type":"journal-article","created":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T14:04:37Z","timestamp":1786284277000},"page":"102615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clonal dynamics on the road to hematological malignancy (MBL, MGUS, CH)"],"prefix":"10.1016","volume":"126","author":[{"given":"Xie","family":"Zhuoer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sekar","family":"Aswin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghia","family":"Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer A.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2026.102615_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-026-01528-5","article-title":"Monoclonal gammopathy of clinical significance: a multisystem review","volume":"16","author":"Sra","year":"2026","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.semcancer.2026.102615_bib2","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1016\/S2352-3026(22)00069-2","article-title":"Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study","volume":"9","author":"El-Khoury","year":"2022","journal-title":"Lancet Haematol."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102615_bib3","article-title":"Monoclonal B-Cell Lymphocytosis: The Silent Clone the Haematologists Should Not Neglect","volume":"43","author":"Serafin","year":"2025","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.semcancer.2026.102615_bib4","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1182\/bloodadvances.2024013228","article-title":"Clonal hematopoiesis of indeterminate potential as a prognostic factor: a systematic review and meta-analysis","volume":"8","author":"Singh","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.semcancer.2026.102615_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/j.seminhematol.2024.01.004","article-title":"A tower of babel of acronyms? The shadowlands of MGUS\/MBL\/CHIP\/TCUS","volume":"61","author":"Bravo-Perez","year":"2024","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.semcancer.2026.102615_bib6","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1016\/S2352-3026(23)00086-8","article-title":"Monoclonal B-cell lymphocytosis, monoclonal gammopathy of undetermined significance, and T-cell clones of uncertain significance: are these premalignant conditions sharing a common identity?","volume":"10","author":"Semenzato","year":"2023","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.semcancer.2026.102615_bib7","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ccell.2023.04.006","article-title":"Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population","volume":"41","author":"van Zeventer","year":"2023","journal-title":"Cancer Cell."},{"key":"10.1016\/j.semcancer.2026.102615_bib8","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood.2025028417","article-title":"Correlates and consequences of clonal hematopoiesis expansion rate: a 16-year longitudinal study of 6976 women","volume":"146","author":"Pershad","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib9","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200310","article-title":"Prediction of risk for myeloid malignancy in clonal hematopoiesis","volume":"2","author":"Weeks","year":"2023","journal-title":"NEJM Evid."},{"key":"10.1016\/j.semcancer.2026.102615_bib10","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41588-023-01472-1","article-title":"Multiparameter prediction of myeloid neoplasia risk","volume":"55","author":"Gu","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcancer.2026.102615_bib11","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2024024756","article-title":"Risk prediction for clonal cytopenia: multicenter real-world evidence","volume":"144","author":"Xie","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2026.102615_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8292","article-title":"Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms","volume":"10","author":"Wolach","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.semcancer.2026.102615_bib14","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2026.102615_bib15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","article-title":"Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1\u03b2\/NLRP3 Inflammasome","volume":"71","author":"Sano","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.semcancer.2026.102615_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s44161-022-00206-6","article-title":"TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease","volume":"2","author":"Zekavat","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.semcancer.2026.102615_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146076","article-title":"TP53-mediated therapy-related clonal hematopoiesis contributes to doxorubicin-induced cardiomyopathy by augmenting a neutrophil-mediated cytotoxic response","volume":"6","author":"Sano","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.semcancer.2026.102615_bib18","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/CIRCRESAHA.121.319314","article-title":"The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice","volume":"129","author":"Yura","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.semcancer.2026.102615_bib19","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1038\/s41375-022-01729-4","article-title":"Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia","volume":"36","author":"Kubota","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2026.102615_bib20","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1038\/s41588-025-02250-x","article-title":"Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy","volume":"57","author":"Liu","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcancer.2026.102615_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41586-022-05448-9","article-title":"Common and rare variant associations with clonal haematopoiesis phenotypes","volume":"612","author":"Kessler","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.102615_bib22","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1182\/blood.2023020817","article-title":"Malignant progression of preleukemic disorders","volume":"143","author":"Hall","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib23","article-title":"Modelling the age-related deceleration of clonal haematopoiesis in UK Biobank","author":"MacGregor","year":"2023","journal-title":"BioRxiv"},{"key":"10.1016\/j.semcancer.2026.102615_bib24","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1158\/2159-8290.CD-24-0751","article-title":"Gene-Specific Machine Learning Models to Classify Driver Mutations in Clonal Hematopoiesis","volume":"14","author":"Arends","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.semcancer.2026.102615_bib25","article-title":"Evolutionary dynamics in the decades preceding acute myeloid leukaemia","author":"Watson","year":"2024","journal-title":"BioRxiv"},{"key":"10.1016\/j.semcancer.2026.102615_bib26","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/s41591-022-01883-3","article-title":"Longitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effects","volume":"28","author":"Robertson","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2026.102615_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180068","article-title":"CHIP: a clonal odyssey of the bone marrow niche","volume":"134","author":"Schleicher","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcancer.2026.102615_bib28","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.stem.2024.05.010","article-title":"Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging","volume":"31","author":"Jakobsen","year":"2024","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.semcancer.2026.102615_bib29","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1158\/2159-8290.CD-25-1584","article-title":"Lingering Effects: Environmental Exposure Leads to Clonal Hematopoiesis via IL1RAP in 9\/11 First Responders","volume":"15","author":"Safina","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.semcancer.2026.102615_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood.2023023788","article-title":"Bone marrow niches for hematopoietic stem cells: life span dynamics and adaptation to acute stress","volume":"144","author":"Hofmann","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41577-023-00843-3","article-title":"Clonal haematopoiesis and dysregulation of the immune system","volume":"23","author":"Belizaire","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2026.102615_bib32","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.3324\/haematol.2020.254987","article-title":"The IL1-IL1RAP axis plays an important role in the inflammatory leukemic niche that favors acute myeloid leukemia proliferation over normal hematopoiesis","volume":"106","author":"De Boer","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2026.102615_bib33","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1158\/2159-8290.CD-21-1146","article-title":"The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation","volume":"12","author":"Yeaton","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.semcancer.2026.102615_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.stem.2018.01.011","article-title":"Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies","volume":"22","author":"Bowman","year":"2018","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.semcancer.2026.102615_bib35","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1158\/2159-8290.CD-21-0901","article-title":"Clonal Hematopoiesis: From Mechanisms to Clinical Intervention","volume":"11","author":"K\u00f6hnke","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.semcancer.2026.102615_bib36","article-title":"Clonal Hematopoiesis Dynamics and Evolutionary Fitness During Cancer Treatment Impact Clinical Outcomes","author":"Arabzadeh","year":"2025","journal-title":"MedRxiv Prepr. Serv. Heal. Sci."},{"key":"10.1016\/j.semcancer.2026.102615_bib37","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","article-title":"Cancer therapy shapes the fitness landscape of clonal hematopoiesis","volume":"52","author":"Bolton","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcancer.2026.102615_bib38","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1182\/bloodadvances.2024012929","article-title":"Impact of cancer therapy on clonal hematopoiesis mutations and subsequent clinical outcomes","volume":"8","author":"Nead","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.semcancer.2026.102615_bib39","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJMoa2413361","article-title":"Tumor-Infiltrating Clonal Hematopoiesis","volume":"392","author":"Pich","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2026.102615_bib40","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/s41588-025-02235-w","article-title":"Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation","volume":"57","author":"Uryu","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcancer.2026.102615_bib41","first-page":"2359","article-title":"Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures","volume":"141","author":"Diamond","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib42","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2026.102615_bib43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jamacardio.2022.0386","article-title":"TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial","volume":"7","author":"Svensson","year":"2022","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.semcancer.2026.102615_bib44","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1182\/bloodadvances.2023011578","article-title":"Effects of IL-1\u03b2 inhibition on anemia and clonal hematopoiesis in the randomized CANTOS trial","volume":"7","author":"Woo","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.semcancer.2026.102615_bib45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1158\/1940-6207.CAPR-23-0342","article-title":"Effect of Clonal Hematopoiesis Mutations and Canakinumab Treatment on Incidence of Solid Tumors in the CANTOS Randomized Clinical Trial","volume":"17","author":"Woo","year":"2024","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.semcancer.2026.102615_bib46","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180069","article-title":"Distinct landscape and clinical implications of therapy-related clonal hematopoiesis","volume":"134","author":"Takahashi","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcancer.2026.102615_bib47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-024-01586-x","article-title":"IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cells","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.semcancer.2026.102615_bib48","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/s41591-021-01521-4","article-title":"Distinction of lymphoid and myeloid clonal hematopoiesis","volume":"27","author":"Niroula","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2026.102615_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12484","article-title":"Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults","volume":"7","author":"Young","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.102615_bib50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2018-01-829937","article-title":"Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A","volume":"132","author":"Buscarlet","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13045-017-0450-y","article-title":"Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia","volume":"10","author":"Quijada-\u00c1lamo","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.semcancer.2026.102615_bib52","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/2159-8290.CD-14-0104","article-title":"Acquired initiating mutations in early hematopoietic cells of CLL patients","volume":"4","author":"Damm","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.semcancer.2026.102615_bib53","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2025030489","article-title":"Clonal Hematopoiesis and Lymphoma-Associated Mutations in Hematopoietic Progenitors in B-Cell Non-Hodgkin Lymphoma","author":"Wiegand","year":"2026","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib54","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ajh.27546","article-title":"Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and Therapy","volume":"100","author":"Hallek","year":"2025","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.semcancer.2026.102615_bib55","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2141.2005.05550.x","article-title":"N. Caporaso, Diagnostic criteria for monoclonal B-cell lymphocytosis","volume":"130","author":"Marti","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.semcancer.2026.102615_bib56","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2026.102615_bib57","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/leu.2009.287","article-title":"Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management","volume":"24","author":"Shanafelt","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2026.102615_bib58","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1182\/blood.2022016279","article-title":"Progression and survival of MBL: a screening study of 10\u2009139 individuals","volume":"140","author":"Slager","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib59","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood-2003-09-3277","article-title":"Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly","volume":"103","author":"Ghia","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib60","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2009-01-197368","article-title":"Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach","volume":"114","author":"Nieto","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib61","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1182\/blood.2020006322","article-title":"Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families","volume":"137","author":"Slager","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41375-021-01344-9","article-title":"Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans","volume":"36","author":"Kleinstern","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2026.102615_bib63","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1056\/NEJMoa075290","article-title":"Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia","volume":"359","author":"Rawstron","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2026.102615_bib64","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood.2020009813","article-title":"The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL","volume":"138","author":"Parikh","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib65","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/ajh.25831","article-title":"Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index","volume":"95","author":"Kleinstern","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.semcancer.2026.102615_bib66","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1182\/blood.2023022180","article-title":"Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature","volume":"143","author":"Abdelbaky","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib67","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/s41375-022-01514-3","article-title":"Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis","volume":"36","author":"Boddicker","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2026.102615_bib68","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41375-020-0799-8","article-title":"Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL)","volume":"35","author":"Shanafelt","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2026.102615_bib69","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1038\/s41375-025-02689-1","article-title":"Progressive T cell defects correlate with disease outcome in high-count monoclonal B-cell lymphocytosis","volume":"39","author":"Parikh","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2026.102615_bib70","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.vaccine.2021.01.001","article-title":"The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL)","volume":"39","author":"Whitaker","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.semcancer.2026.102615_bib71","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ajh.26388","article-title":"Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis","volume":"97","author":"Muchtar","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.semcancer.2026.102615_bib72","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41408-022-00754-x","article-title":"The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis","volume":"12","author":"Parikh","year":"2022","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.semcancer.2026.102615_bib73","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41375-025-02797-y","article-title":"Molecular and functional characterization of the B-cell receptor in chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis","volume":"40","author":"Agathangelidis","year":"2026","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2026.102615_bib74","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1182\/blood-2025-3910","article-title":"Normal B Cells in MBL follow divergent maturation pathways that correlate with the IGHV mutation status of the pre-leukemic clone","volume":"146","author":"Blanco","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib75","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1182\/blood.2021012890","article-title":"High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis","volume":"139","author":"Kolijn","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib76","article-title":"Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL","author":"Agathangelidis","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib77","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1182\/blood-2011-05-357251","article-title":"General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL","volume":"118","author":"Fazi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib78","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3324\/haematol.2017.177212","article-title":"Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations","volume":"103","author":"Agathangelidis","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2026.102615_bib79","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41408-024-01175-8","article-title":"Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL)","volume":"14","author":"Sekar","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.semcancer.2026.102615_bib80","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1038\/s41375-023-01914-z","article-title":"Relationship among three common hematological premalignant conditions","volume":"37","author":"Boddicker","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2026.102615_bib81","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41408-025-01385-8","article-title":"CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL)","volume":"15","author":"Boddicker","year":"2025","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.semcancer.2026.102615_bib82","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1182\/blood.2025029905","article-title":"The landscape and evolution of clonal hematopoiesis in chronic lymphocytic leukemia","volume":"147","author":"Al-Sawaf","year":"2026","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib83","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1200\/JCO.2016.71.6712","article-title":"Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma","volume":"35","author":"Gibson","year":"2017","journal-title":"J. Clin. Oncol. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2026.102615_bib84","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib85","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/cncr.27719","article-title":"Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia","volume":"119","author":"Shanafelt","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2026.102615_bib86","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1182\/bloodadvances.2023011458","article-title":"Vitamin D supplement for patients with early-stage chronic lymphocytic leukemia is associated with a longer time to first treatment","volume":"8","author":"Tadmor","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.semcancer.2026.102615_bib87","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMra2412716","article-title":"Monoclonal Gammopathy of Undetermined Significance","volume":"393","author":"Rajkumar","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2026.102615_bib88","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.semcancer.2026.102615_bib89","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study","volume":"375","author":"Dispenzieri","year":"2010","journal-title":"Lancet (Lond. Engl. )"},{"key":"10.1016\/j.semcancer.2026.102615_bib90","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2026.102615_bib91","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41408-021-00408-4","article-title":"Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report","volume":"11","author":"Murray","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.semcancer.2026.102615_bib92","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41408-019-0263-z","article-title":"Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement","volume":"9","author":"Murray","year":"2019","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.semcancer.2026.102615_bib93","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41408-021-00480-w","article-title":"Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies","volume":"11","author":"R\u00f6gnvaldsson","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.semcancer.2026.102615_bib94","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.mayocp.2012.06.014","article-title":"Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition","volume":"87","author":"Therneau","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.semcancer.2026.102615_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.97","article-title":"Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey","volume":"7","author":"Landgren","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.semcancer.2026.102615_bib96","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/leu.2014.34","article-title":"Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey","volume":"28","author":"Landgren","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2026.102615_bib97","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/S0025-6196(11)61089-6","article-title":"Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana","volume":"82","author":"Landgren","year":"2007","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.semcancer.2026.102615_bib98","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/bloodadvances.2021006201","article-title":"Prevalence of heavy chain MGUS by race and family history risk groups using a high-sensitivity screening method","volume":"6","author":"Vachon","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.semcancer.2026.102615_bib99","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood-2008-12-192575","article-title":"Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance","volume":"114","author":"Vachon","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1182\/blood-2017-09-807560","article-title":"How I manage monoclonal gammopathy of undetermined significance","volume":"131","author":"Go","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.102615_bib101","doi-asserted-by":"crossref","unstructured":"A simple genomic score to predict progression of multiple myeloma., Nat Genet 57 (2025) 1332\u20131333. https:\/\/doi.org\/10.1038\/s41588-025-02199-x.","DOI":"10.1038\/s41588-025-02199-x"},{"key":"10.1016\/j.semcancer.2026.102615_bib102","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/s41588-025-02196-0","article-title":"Genomic landscape of multiple myeloma and its precursor conditions","volume":"57","author":"Alberge","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcancer.2026.102615_bib103","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41571-026-01119-0","article-title":"Diagnosis, risk stratification and management of smouldering multiple myeloma","volume":"23","author":"Zanwar","year":"2026","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2026.102615_bib104","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2026.102615_bib105","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X2600074X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X2600074X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:46:11Z","timestamp":1791816371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X2600074X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":105,"alternative-id":["S1044579X2600074X"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2026.102615","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clonal dynamics on the road to hematological malignancy (MBL, MGUS, CH)","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2026.102615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102615"}}